国泰中证生物医药ETF联接E (022498.jj ) CS生医 (半年) 国泰基金管理有限公司申 | 基金经理梁杏基金类型指数型基金(ETF,联接型)成立日期2024-11-21总资产规模 (2025-12-31) 基金净值1.0100元 (2026-04-15) 管理费用率0.50%管托费用率0.10% (2025-09-30) 成立以来分红再投入年化收益率2.21% (4376 / 5780) |
| 相关基金: | 主从基金: 国泰中证生物医药ETF联接C 、国泰中证生物医药ETF联接A目标基金: 国泰中证生物医药ETF |
| 备注 (0): | 双击编辑备注 |
国泰中证生物医药ETF联接E(022498) - 基金对比
最后更新于：2026-04-15
非全收益率指数点位的计算不包含分红再投入，所以理论上指数基金的分红再投入收益率高于其对应的指数点位涨幅。
加载中......
| 日期 | 国泰中证生物医药ETF联接E - 相对起始点分红再投入收益率 | CS生医 - 相对起始点收益率 |
|---|---|---|
| 2026-04-15 | 3.10% | 5.45% |
| 2026-04-14 | 1.87% | 4.11% |
| 2026-04-13 | 1.01% | 3.19% |
| 2026-04-10 | 1.43% | 3.64% |
| 2026-04-09 | 1.03% | 3.21% |
| 2026-04-08 | 2.29% | 4.57% |
| 2026-04-07 | 0.20% | 2.30% |
| 2026-04-03 | 0.36% | 2.47% |
| 2026-04-02 | 2.76% | 5.06% |
| 2026-04-01 | 3.15% | 5.49% |
| 2026-03-31 | -0.89% | 1.11% |
| 2026-03-30 | -0.58% | 1.44% |
| 2026-03-27 | -1.21% | 0.75% |
| 2026-03-26 | -4.68% | -3.00% |
| 2026-03-25 | -3.45% | -1.69% |
| 2026-03-24 | -3.89% | -2.16% |
| 2026-03-23 | -6.60% | -5.10% |
| 2026-03-20 | -2.94% | -1.15% |
| 2026-03-19 | -1.61% | 0.28% |
| 2026-03-18 | -0.11% | 1.92% |
| 2026-03-17 | -0.49% | 1.51% |
| 2026-03-16 | -1.15% | 0.78% |
| 2026-03-13 | -1.63% | 0.27% |
| 2026-03-12 | -1.04% | 0.91% |
| 2026-03-11 | -0.14% | 1.88% |
| 2026-03-10 | 0.60% | 2.69% |
| 2026-03-09 | -1.60% | 0.29% |
| 2026-03-06 | -0.40% | 1.58% |
| 2026-03-05 | -2.82% | -1.04% |
| 2026-03-04 | -3.29% | -1.54% |
| 2026-03-03 | -2.24% | -0.41% |
| 2026-03-02 | 0.08% | 2.09% |
| 2026-02-27 | 2.41% | 4.63% |
| 2026-02-26 | 2.78% | 5.01% |
| 2026-02-25 | 4.11% | 6.47% |
| 2026-02-24 | 3.31% | 5.59% |
| 2026-02-13 | 3.65% | 5.94% |
| 2026-02-12 | 5.05% | 7.46% |
| 2026-02-11 | 5.19% | 7.60% |
| 2026-02-10 | 5.22% | 7.63% |
| 2026-02-09 | 4.16% | 6.50% |
| 2026-02-06 | 3.73% | 6.02% |
| 2026-02-05 | 4.24% | 6.58% |
| 2026-02-04 | 4.25% | 6.58% |
| 2026-02-03 | 3.11% | 5.34% |
| 2026-02-02 | 1.89% | 4.01% |
| 2026-01-30 | 4.24% | 6.57% |
| 2026-01-29 | 5.91% | 8.39% |
| 2026-01-28 | 5.05% | 7.43% |
| 2026-01-27 | 6.26% | 8.75% |